The Heart Failure Association of the European Society of Cardiology has recently proposed to optimize guidelines-directed medical treatments according to patient's profiles. Aim of this anal...
Transcatheter Aortic Valve Implantation (TAVI) has emerged over time, reflected in appropriate adjustments in the European Society of Cardiology (ESC) guidelines in 2007, 2012 and 2017.The a...
The European Society of Cardiology (ESC) clinical practice guidelines are essential tools for decision-making.To analyze the level of evidence (LOE) and the class of recommendations in the E...
Electrophysiological testing has been proposed in the latest European Society of Cardiology (ESC) guidelines for cardiac pacing to identify left bundle branch block (LBBB) patients with infr...
Previous research has shown an association of higher heart rate with an increased risk of atrial fibrillation (AF). However, the relationship between resting heart rate (RHR) and AF is unkno...
Atrial fibrillation (AF) is the most common cardiac arrhythmia in critically unwell patients. New-onset AF (NOAF) affects 5%-11% of all admissions and up to 46% admitted with septic shock. N...
Preliminary results from the PLAN-MARSHALL trial revealed that the Marshall Plan ablation strategy may outperform pulmonary vein isolation (PVI) alone regarding the recurrence of atrial fibr...
The previous ANTWOORD I study evaluated the ANTWERP score, which predicts left ventricular ejection fraction (LVEF) recovery after ablation in patients with HF and AF, scoring patients who...
A population-based study including more than 51,000 patients with atrial fibrillation (AF) showed compared with non-use of statins, statin use was linked with a lower risk for ischemic strok...
The primary results of the CEASE-AF trial demonstrated that hybrid ablation—epicardial plus endocardial ablation—was superior to endocardial ablation alone in reducing atrial arrhythmi...
Compared with standard EKG monitoring, prolonged EKG monitoring led to the detection of significantly more arrhythmias in patients with non-high-risk hypertrophic cardiomyopathy (HCM). Th...
To assess the self-reported symptom burden in patients with a diagnosis of heart failure attending an outpatient cardiology clinic through the utilisation of validated patient-reported outco...
While the US Food and Drug Administration (FDA) has cleared smartwatch software for detecting atrial fibrillation (AF), there is lack of guidance on management by physicians. We sought to ev...
A substudy of the POWER FAST III trial demonstrated that a high-power, short-duration radiofrequency (HPSD RF) application for pulmonary vein isolation (PVI) is associated with a higher ri...
Patients with atrial fibrillation (AF) undergoing a first ablation using the pentaspline pulsed-field ablation (PFA) catheter had a “1 year of freedom from an AF” recurrence rate of 78...
Preliminary results of the POWER FAST III trial showed that high-power, short-duration radiofrequency (HPSD RF) pulmonary vein isolation (PVI) was non-inferior to low-power, long-duration (L...
It is feasible to treat patients with symptomatic atrial fibrillation (AF) with antiarrhythmic drugs (AADs) for at least 1 year without hampering the outcomes of subsequent ablation, accor...
The POTTER-AF study revealed that a surgical or endoscopic intervention is necessary to reduce the risk for death in patients with esophageal fistula (EF) following catheter ablation for a...
High blood pressure (BP) or hypertension is a well known risk factor for developing heart attack, stroke, atrial fibrillation and renal failure. Although in the past hypertension was suppose...
Over the course of 2022, numerous key clinical trials with valuable contributions to clinical cardiology were published or presented at major international conferences. This review seeks to ...
The latest articles and insights from your colleagues in your specialty(ies) of choice.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
